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Public Health has several important tools in its arsenal, 
including screening for diseases and offering the public 
various vaccinations. Qatar introduced an important 
programme this year, offering Human Papilloma Virus 
(HPV) vaccination. 
    Cervical cancer is among the top ten cancers in the 
world with an estimate of 527,624 new cases and 265,672 
deaths in 2012. [1] Cervical cancer constitutes an age-
standardized incidence rate (ASIR) of 5.1 per 100,000 and 
age-standardized death rate (ASDR) of 2.4 per 100,000 in 
Qatar. [1] In addition, it is the fifth most common cancer 
among women, in the State of Qatar. Cervical cancer 
screening services are free in the primary health care 
corporation (PHCC), but it is difficult to make an 
appointment. It can take more than one month to get an 
appointment with a general physician and subsequently 
there is a further delay of several weeks in getting a 
referral consultation to a well women clinic for cervical 
cancer screening. Similar problems have been found in 
England, where Waller and colleagues showed that 
‘difficulty to make an appointment’ was a barrier to 
cervical cancer screening. [2]  
    In January 2018, the Qatar Cancer Society (QCS) 
launched ‘Darbek Khadar’, its one-month campaign. The 
aim of this campaign is to raise awareness about cervical 
cancer and the importance of early screening. In addition, 
it also aimed to increase the willingness among the 
population to get a Pap smear test. This campaign will 
return in the month of January every year. This year, as 
part of the 2018 campaign women have come forward for 
a free Pap smear test at Al Emadi and Al Ahli hospitals. 
[3] The Qatari campaign recognized the development of 
primary health care development in the introduction and 
management of cervical cancer screening services [4].   In 
Qatar screening is offered to women aged 21 and over 
every three years until age 49, and every five years for 
women aged between 50 and 64. 
    QCS also organized a lucky draw among women who 
underwent the Pap smear test at Ritz Carlton Hotel on 28 
January 2018. This was mainly to increase willingness 
among women to come forward. This event included an 
interactive session with the health educators about cervical 
cancer. It was a great initiative by QCS, but there were 
some pitfalls. Even though it was for the whole population 
including foreign workers (or expatriates), some people 
were not aware of this programme. Areas that could have 
been improved were the ways to draw public attention to 
the programme. Mass media advertising could have been 
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used to inform the public about the event through phone 
calls, personalized invitations and appointment letters, 
reminder letters, brochures, and pamphlets in different 
languages. The two main telephone service providers in 
Qatar, Ooredoo and Vodafone could have been involved 
in this event. 
    If QCS could address the publicity issue in the future, 
then foreign workers, who cannot afford the cost for Pap 
smear test [around 100 USD] could also benefit from this 
campaign. QCS can also consider a self-sample collection 
method (by post for example) by women in the future. 
PHCC, QCS, HMC (Hamad Medical Corporation) and the 
MoPH (Ministry of Public Health) should work together 
to offer the best possible practice in cancer screening. 
    In February 2018, Dr. Hamad Eid al-Rumaihi, Director 
of Health Protection and Communicable Disease at the 
MoPH announced that Qatar will launch HPV vaccination 
during International Vaccination Week in April 2018. [5]  
Qatar needs to be aware that similar initiatives in other 
countries have reported several factors directly affecting 
the local population’s willingness to get an HPV 
vaccination.  These factors, or barriers, include ethnicity, 
educational status, and awareness of HPV and its 
vaccination. [6-7] We argue that there is an urgent need to 
study the local population’s willingness to seek an HPV 
vaccination. This would require a large population-based 
study covering the key sub-groups in Qatar’s population 
before the implementation of the vaccination programme. 
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